Nature Communications (Oct 2022)

METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions

  • Yuanpei Li,
  • Xiaoniu He,
  • Xiao Lu,
  • Zhicheng Gong,
  • Qing Li,
  • Lei Zhang,
  • Ronghui Yang,
  • Chengyi Wu,
  • Jialiang Huang,
  • Jiancheng Ding,
  • Yaohui He,
  • Wen Liu,
  • Ceshi Chen,
  • Bin Cao,
  • Dawang Zhou,
  • Yufeng Shi,
  • Juxiang Chen,
  • Chuangui Wang,
  • Shengping Zhang,
  • Jian Zhang,
  • Jing Ye,
  • Han You

DOI
https://doi.org/10.1038/s41467-022-34209-5
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 23

Abstract

Read online

METTL3 catalyzes mRNA m6A deposition. The authors identify an acetylation-mediated regulation of METTL3 subcellular localization and compartment-specific functions, a process that is fine-tuned by anti-inflammatory and pro-inflammatory signals, which ultimately determine breast cancer metastasis.